Clinical Trials Directory

Trials / Terminated

TerminatedNCT02529891

Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Exacerbations of the disease are a hallmark of Chronic Obstructive Pulmonary Disease (COPD), affecting the decline of pulmonary function, quality of life and increasing morbidity. The use of validated biomarkers could help to identify the etiology of exacerbation and to prescribe antibiotherapy when indicated. The analysis of exhaled air allows measuring different volatile organic compounds (VOC) which reflect local or systemic inflammation and oxidative stress. The relationship between the presence of some of these compounds and the exacerbation of COPD has never been studied. The aim of this study is to identify a cluster of VOC in COPD patients during an acute exacerbation of the disease, compared to a stable condition (3 months after discharge). Investigators also will seek for a relationship between VOC and the etiology of exacerbation (bacterial, viral, inflammatory).

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of VOC in exhaled airMeasurement of VOC in exhaled air during 10 min (tidal breathing) with a portable mass spectrometer

Timeline

Start date
2014-08-08
Primary completion
2017-10-17
Completion
2017-10-17
First posted
2015-08-20
Last updated
2017-10-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02529891. Inclusion in this directory is not an endorsement.